We are live on ! Find out more
CCC

Crescent Capital Consulting Portfolio holdings

AUM $607M
1-Year Est. Return 22.88%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+22.88%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$534M
AUM Growth
+$78.2M
Cap. Flow
+$75.8M
Cap. Flow %
14.19%
Top 10 Hldgs %
38.48%
Holding
571
New
47
Increased
80
Reduced
111
Closed
70

Similar funds

Crescent Capital Consulting's Q2 2021 Portfolio in Review

As of Q2 2021, Crescent Capital Consulting held 571 positions worth $534M, up 17% from $456M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Crescent Capital Consulting deployed $75.8M of net new capital in Q2 2021, opening 47 new positions and adding to 80 existing holdings. Its largest new stake was Invesco BulletShares 2023 High Yield Corporate Bond ETF: 613,192 shares worth $15.6M.

By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.5% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Invesco BulletShares 2021 High Yield Corporate Bond ETF, an estimated $10.8M trimmed.

  • Crescent Capital Consulting's largest Q2 2021 buy was Invesco BulletShares 2023 High Yield Corporate Bond ETF: 613,192 shares worth $15.6M.
  • Crescent Capital Consulting added most to iShares Russell 1000 Growth ETF in Q2 2021, an estimated $27.1M increase.
  • Crescent Capital Consulting's biggest Q2 2021 reduction was Invesco BulletShares 2021 High Yield Corporate Bond ETF, cutting an estimated $10.8M.
  • Crescent Capital Consulting fully exited State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q2 2021, selling an estimated $273K.
  • Crescent Capital Consulting's ten largest holdings make up 38% of its $534M portfolio in Q2 2021.
  • Crescent Capital Consulting opened 47 new positions and closed 70 in Q2 2021.
  • Crescent Capital Consulting's portfolio value rose 17% quarter-over-quarter to $534M.

Based on Crescent Capital Consulting's 13F filing for Q2 2021, filed 15 Jul 2021.